Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

69.36 -3.62 (-4.96%)
Official Closing Price Updated: 4:10 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
From Edwards Lifesciences Corporation
Via Business Wire
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
Via Benzinga
A Look Into Edwards Lifesciences Inc's Price Over Earnings
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
11 Analysts Have This To Say About Edwards Lifesciences
Via Benzinga
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
From Edwards Lifesciences Corporation
Via Business Wire
Top S&P500 movers in Wednesday's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company projects continued expansion in 2025. 
Via Benzinga
These S&P500 stocks are moving in today's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts
Via Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Discover the top S&P500 movers in Wednesday's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Edwards Beats Fourth-Quarter Forecasts, But Shares Slip
Edwards Lifesciences stock fell slightly late Tuesday after the company kept its outlook for 2025 despite beating forecasts. 
Via Investor's Business Daily
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
U.S. 
Via Benzinga
Earnings Scheduled For February 11, 2025
Via Benzinga
Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings
Medical technology company Edwards Lifesciences (NYSE:EW) will be reporting results tomorrow after market close. Here’s what to look for. 
Via StockStory
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
From Kahn Swick & Foti, LLC
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025. 
Via Benzinga
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
From Kahn Swick & Foti, LLC
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Jan. 18
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Jan. 13-17, 2025. 
Via Talk Markets
Topics Stocks / Equities
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Good technical signals and a possible breakout for EDWARDS LIFESCIENCES CORP.
EDWARDS LIFESCIENCES CORP (NYSE:EW) has a strong technical rating of 7 out of 10, indicating a potential breakout. 
Via Chartmill
EDWARDS ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Technical Signals Point to a Possible Breakout for EDWARDS LIFESCIENCES CORP.
With a solid technical rating of 7 out of 10, EDWARDS LIFESCIENCES CORP (NYSE:EW) is showing strong indications of a possible breakout. 
Via Chartmill
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.